SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Oscient Pharmaceuticals Corp. (OSCI) -- Ignore unavailable to you. Want to Upgrade?


To: Andrew Danielson who wrote (599)2/12/2000 5:48:00 AM
From: OldAIMGuy  Respond to of 1154
 
Hi AD, This could be important to the future of GENE's price activity. As far as I know, GENE never had listed options before.

"Genome Therapeutics's GUG options will trade on the January expiration cycle with introductory expirations in March, April, July and October. Initial strike prices have been set at 22-1/2, 25 and 30."

Looks like they'll have to price some a bit higher now! :-)

Best regards, Tom